At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...